Docline maintains an agreement with Mapfre, with whom it offers digital health programs to the company's policyholders; with the Ballesol retirement home company, to whose patients it...
Sicit specializes in the transformation of leather by-products into biostimulants for agriculture and retardants for the gypsum industry. The company offers a strategically important service for...
Looking ahead to 2024, the group plans to reach break-even, when the European Medicines Agency approves its drug against glioblastoma, an aggressive type of cancer that...
The company, which has 37 people on its staff, generates 80% of its turnover in the Spanish market and the remaining 20% in various international markets, including...
In November, Miwendo developed a first clinical study, and will now work on a second, both at the Hospital Clínic in Barcelona. The device, which the...
Qubiotech uses Artificial Intelligence-based image processing to develop diagnostics for brain diseases, which it has called Neurocloud. The software hosts three medical image quantification algorithms (PET,...
The Catalan pharmaceutical company Almirall earned €4.3 million in 2022 and surpassed the losses of €40.9 million it had in 2021. The normalized net result, which...
Once this round is completed, Mikrobiomik plans to initiate a new financing round with the aim of raising €6 million, in which it plans to include...
Boehringer Ingelheim reached a sales figure of €24.1 billion in 2022, which translates into a year-on-year rise of 10.5%. In 2022, the Spanish subsidiary registered an...
Prim aims to achieve sales of €305 million by 2025. The company founded in 1870 expects that by that date 25% of its business will come...